Received Feb 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 3 | 947356 | IM / LA |
Heplisav-B is recommend to be given only two doses which patient completed the series, this is the third vaccine that she recieved, she did not report any adverse reation outside of typical soreness in the arm Two previous doses were given on 11/17/25 and 12/18/25
None
None
Norethindrone Ace/Ethy 1/20
None
None